Chronic asymptomatic pyuria precedes overt urinary tract infection and deterioration of renal function in autosomal dominant polycystic kidney disease

被引:28
|
作者
Hwang, Jin Ho [1 ]
Park, Hayne Cho [1 ,2 ]
Jeong, Jong Cheol [1 ]
Baek, Seon Ha [1 ]
Han, Mi Yeun [1 ]
Bang, Kitae [3 ]
Cho, Jeong Yeon [4 ]
Yu, Suk Hee [5 ]
Yang, Jaeseok [6 ]
Oh, Kook-Hwan [1 ]
Hwang, Young-Hwan [2 ,7 ]
Ahn, Curie [1 ,2 ,6 ]
机构
[1] Seoul Natl Univ Hosp, Dept Internal Med, 101 Daehak No, Seoul 110744, South Korea
[2] Seoul Natl Univ Hosp, Res Ctr Rare Dis, Seoul 110744, South Korea
[3] Daejeon Eulji Univ Hosp, Dept Internal Med, Taejon, South Korea
[4] Seoul Natl Univ Hosp, Dept Radiol, Seoul 110744, South Korea
[5] Chung Ang Univ Hosp, Dept Internal Med, Seoul, South Korea
[6] Seoul Natl Univ Hosp, Transplantat Ctr, Seoul 110744, South Korea
[7] Eulji Gen Hosp, Dept Internal Med, Seoul, South Korea
来源
BMC NEPHROLOGY | 2013年 / 14卷
关键词
Polycystic kidney disease; Chronic renal failure; Glomerular filtration rate; Pyuria; Urinary tract infection; CYST FORMATION; PROGRESSION; ADPKD; PKD1; MICE; INACTIVATION; CYSTOGENESIS; PATHOGENESIS; PREVALENCE; DIAGNOSIS;
D O I
10.1186/1471-2369-14-1
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: Urinary tract infection (UTI) occurs in 30%-50% of individuals with autosomal dominant polycystic kidney disease (ADPKD). However, the clinical relevance of asymptomatic pyuria in ADPKD patients remains unknown. Methods: We retrospectively reviewed medical records of 256 ADPKD patients who registered to the ADPKD clinic at Seoul National University Hospital from Aug 1999 to Aug 2010. We defined the asymptomatic pyuria as more than 5-9 white blood cells in high-power field with no related symptoms or signs of overt UTI. Patients were categorized into 2 groups depending on its duration and frequency: Group A included non-pyuria and transient pyuria patients; Group B included recurrent and persistent pyuria patients. The association between asymptomatic pyuria and both the development of overt UTI and the deterioration of renal function were examined. Results: With a mean follow-up duration of 65.3 months, 176 (68.8%) out of 256 patients experienced 681 episodes of asymptomatic pyuria and 50 episodes of UTI. The annual incidence of asymptomatic pyuria was 0.492 episodes/patient/year. The patients in group B showed female predominance (58.5% vs. 42.0%, P=0.01) and experienced an upper UTI more frequently (hazard ratio: 4.612, 95% confidence interval: 1.735-12.258; P=0.002, adjusted for gender and hypertension). The annual change in estimated glomerular filtration rate (Delta eGFR) was significantly larger in magnitude in group B than in group A (-2.7 +/- 4.56 vs. -1.17 +/- 5.8, respectively; P=0.01). Age and Group B found to be the independent variables for Delta eGFR and developing end-stage renal disease (16.0% vs. 4.3%, respectively; P=0.001). Conclusions: Chronic asymptomatic pyuria may increase the risk of developing overt UTI and may contribute to declining renal function in ADPKD.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] Renal disease progression in autosomal dominant polycystic kidney disease
    Higashihara, Eiji
    Horie, Shigeo
    Muto, Satoru
    Mochizuki, Toshio
    Nishio, Saori
    Nutahara, Kikuo
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2012, 16 (04) : 622 - 628
  • [22] Renal disease progression in autosomal dominant polycystic kidney disease
    Eiji Higashihara
    Shigeo Horie
    Satoru Muto
    Toshio Mochizuki
    Saori Nishio
    Kikuo Nutahara
    Clinical and Experimental Nephrology, 2012, 16 : 622 - 628
  • [23] Urinary Biomarkers in Monitoring the Progression and Treatment of Autosomal Dominant Polycystic Kidney Disease-The Promised Land?
    Pana, Camelia
    Stanigut, Alina Mihaela
    Cimpineanu, Bogdan
    Alexandru, Andreea
    Salim, Camer
    Nicoara, Alina Doina
    Resit, Periha
    Tuta, Liliana Ana
    MEDICINA-LITHUANIA, 2023, 59 (05):
  • [24] Cyst Infection in Autosomal Dominant Polycystic Kidney Disease
    Wang, I-kuan
    Liang, Chih-Chia
    Chen, Yung-Fang
    Huang, Chiu-Ching
    INTERNAL MEDICINE, 2012, 51 (13) : 1803 - 1803
  • [25] Management of renal cyst infection in patients with autosomal dominant polycystic kidney disease: a systematic review
    Lantinga, Marten A.
    Casteleijn, Niek F.
    Geudens, Alix
    de Sevaux, Ruud G. L.
    van Assen, Sander
    Leliveld, Anna M.
    Gansevoort, Ron T.
    Drenth, Joost P. H.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32 (01) : 144 - 150
  • [26] Kidney volume and function in autosomal dominant polycystic kidney disease
    Eiji Higashihara
    Kikuo Nutahara
    Takatsugu Okegawa
    Toshihide Shishido
    Mitsuhiro Tanbo
    Kuninori Kobayasi
    Toshiaki Nitadori
    Clinical and Experimental Nephrology, 2014, 18 : 157 - 165
  • [27] Vascular Function Impairment Precedes Decline in Renal Function in a Model of Autosomal Recessive Polycystic Kidney Disease
    Dennis, Melissa
    Gauthier, Madeline
    Morales, Mark
    Messieh, Alexandra
    Pires, Paulo
    Banek, Christopher
    PHYSIOLOGY, 2023, 38
  • [28] Outcome of renal replacement therapy in autosomal dominant polycystic kidney disease
    Pirson, Y
    Christophe, JL
    Goffin, E
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1996, 11 : 24 - 28
  • [29] Factors Influencing Cyst Infection in Autosomal Dominant Polycystic Kidney Disease
    Suwabe, Tatsuya
    Ubara, Yoshifumi
    Hayami, Noriko
    Yamanouchi, Masayuki
    Hiramatsu, Rikako
    Sumida, Keiichi
    Sawa, Naoki
    Sekine, Akinari
    Kawada, Masahiro
    Hasegawa, Eiko
    Hoshino, Junichi
    Takaichi, Kenmei
    NEPHRON, 2019, 141 (02) : 75 - 86
  • [30] Short-term effects of tolvaptan on renal function and volume in patients with autosomal dominant polycystic kidney disease
    Irazabal, Maria V.
    Torres, Vicente E.
    Hogan, Marie C.
    Glockner, James
    King, Bernard F.
    Ofstie, Troy G.
    Krasa, Holly B.
    Ouyang, John
    Czerwiec, Frank S.
    KIDNEY INTERNATIONAL, 2011, 80 (03) : 295 - 301